Multicenter Study on Coronary Anomalies in The Netherlands

Multicenter Study on Coronary Anomalies in The Netherlands - MuSCAT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55795

Enrollment

280

Registered

2020-05-04

Start date

2021-01-19

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aberrant coronary artery coronary artery anomaly

Interventions

All examinations that will be done are currently routinely used for diagnostic purposes of ACAOS. Though, different hospitals use different examinations. All tests will be done according to their st

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Presence of coronary artery anomaly, including anomalous coronary artery originating from opposite sinus or artery (ACAOS), coronary arteriovenous fistulas (CAVF), anomalous coronary arteries from pulmonary artery (ALPACA/ARCAPA)

Exclusion criteria

Exclusion criteria: - A medical history of hemodynamically significant congenital heart defect other than an ACAOS, CAVF or ALCAPA/ARCAPA - Proven coronary atherosclerotic disease

Design outcomes

Secondary

Measure	Time frame
Quality of life according to the SF-36 questionnaire and the nature of the, if present, anginal complaints, i.e. typical, atypical or non-anginal, heart failure demanding medical treatment (mainly applicable in cases of ALCAPA/ARCAPA and CAVFs), exercise ability.	—

Primary

Measure	Time frame
Combined endpoint of (cardiac) death, myocardial infarction in anomalous vessel, re-intervention after surgical correction of ACAOS.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)